Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug? | Dementia and Cognitive Impairment | JAMA : vimarsana.com

Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug? | Dementia and Cognitive Impairment | JAMA

This Medical News story examines the complexity of determining who to treat with lecanemab, the new Alzheimer disease drug.

Related Keywords

United Kingdom , Ohio , United States , New York , Kansas , Minnesota , George Perry , Donna Wilcock , Eli Lilly , Russell Swerdlow , James Burke , Sam Grandy , Madhav Thambisetty , Alzeca Bioscience , Robert Howard , Libby Holman , Ivan Cheung , Xavier Becerra , David Knopman , Allison Parks , Bioenergetically Active Esters For Health , Recuerdo Pharmaceuticals , Cure Alzheimer Fund , Alzheimer Network For Treatment , Us Department Of Health , York Stem Cell Foundation , University Of Texas At San Antonio , Translational Neuroscience Section Laboratory Of Behavioral , Centers For Medicare Medicaid Services , National Institutes Of Health , Brightfocus Foundation , Mcknight Brain Research Foundation , Indiana University , Indiana University School Of Medicine , National Institute On Aging , Pfizer , Drug Administration , Lilly Pharmaceuticals , University Of Kansas Alzheimer Disease Research Center , Astrazeneca , Nestle Health Science , Journal Of The Alzheimer Association , University College London , Human Services , Alzheimer Network Treatment Unit , University Of Southern California , Alzheimer Association , Johnson , Kansas Alzheimer Disease Research , San Antonio , Might Benefit , Who Might , New England Journal , Indiana University School , Ohio State , Medicaid Services , Monoclonal Antibodies Directed Against Amyloid , Disease Registry , Alzheimer Network , Chiquita Brooks Lasure , National Institutes , National Institute , Translational Neuroscience Section Laboratory , Mount Sinai , Mayo Clinic Study , Interest Disclosures , Cognito Therapeutics , Third Bridge , Vigil Neurosciences , Cure Alzheimer , New York Stem Cell Foundation , Southern California , Samus Therapeutics , Active Esters , Nestle Health , Central Nervous System , Psychopharmacologic Drugs ,

© 2024 Vimarsana